About Translatale Biosystems
Translatale Biosystems is a company based in Bengaluru (India) founded in 2022 by Saurabh Mahajan and Gnaneshwar Yadav. The company has 1 employees as of April 07, 2024. Translatale Biosystems offers products and services including Biological Platforms. Translatale Biosystems operates in a competitive market with competitors including Noetik, Function Oncology, Meliora Therapeutics, Transition Bio and Alixia, among others.
- Headquarter Bengaluru, India
- Employees 1 as on 07 Apr, 2024
- Founders Saurabh Mahajan, Gnaneshwar Yadav
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Translatale Biosystems Private Limited
- Date of Incorporation 31 Oct, 2022
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Translatale Biosystems
Translatale Biosystems offers a comprehensive portfolio of products and services, including Biological Platforms.
Platforms for detecting drug impacts on mRNA translation processes.
Funding Insights of Translatale Biosystems
Detailed funding history for Translatale Biosystems
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Translatale Biosystems
Investment portfolio details for Translatale Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Translatale Biosystems
Detailed financials for Translatale Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Translatale Biosystems Comparisons
Peer comparison for Translatale Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Translatale Biosystems
Translatale Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noetik, Function Oncology, Meliora Therapeutics, Transition Bio and Alixia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cancer immunotherapies are discovered and developed via AI platform.
|
|
| Locked | Locked | Locked |
Cancer therapeutics are developed using a CRISPR-enabled platform.
|
|
| Locked | Locked | Locked |
Machine learning-driven platform for oncology drug discovery is offered.
|
|
| Locked | Locked | Locked |
Technology platform for biomolecular condensate analysis is developed.
|
|
| Locked | Locked | Locked |
Cancer drug discovery platform is provided for tumor mutation targeting.
|
|
| Locked | Locked | Locked |
Web-based solutions for genomic testing and sequencing access are provided.
|
Detailed competitors of Translatale Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Translatale Biosystems
Complete news archive for Translatale Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Translatale Biosystems
Translatale Biosystems was founded in 2022.
Translatale Biosystems is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Gnaneshwar Yadav is the current CEO of Translatale Biosystems. They have also founded this company.
As of Apr 07, 2024, the latest employee count at Translatale Biosystems is 1.
Translatale Biosystems was founded in 2022 and is based in Bengaluru, India. Operations focus on a platform that integrates experimental and data-driven techniques for screening small molecules. These efforts target mRNA translation modulation in diseases including cancer, neurodegenerative conditions, and rare disorders. The biotechnology sector benefits from this approach in early-stage drug discovery processes.
Translatale Biosystems's top competitors include Noetik, Transition Bio and Function Oncology.
Translatale Biosystems offers Biological Platforms.